Relação Neutrófilo-Linfócito: Acrescentando um Biomarcador a uma Escala Preditiva de Pneumonia Pós-Acidente Vascular Cerebral

Autores

  • Diogo Pedro Serviço de Doenças Infeciosas, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal
  • Marco Narciso Serviço de Medicina III, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal
  • Mariana Alves Serviço de Medicina III, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal
  • Teresa Passos Fonseca Serviço de Medicina III, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal

DOI:

https://doi.org/10.24950/rspmi.2022.01.o

Palavras-chave:

Acidente Vascular Cerebral/complicações, Linfócito, Neutrófilo, Pneumonia

Resumo

Introdução: Avaliar a associação da relação neutrófilo-linfócito (NLR) e a incidência de pneumonia pós-acidente vascular cerebral (PSP), subtipo de acidente vascular cerebral (AVC), gravidade e prognóstico.

Material e Métodos: Foi realizado um estudo prospetivo observacional durante um período de 42 meses numa Unidade de AVC de um hospital terciário. Todos os doentes com AVC isquémico agudo (AIS) foram sequencialmente incluídos. O valor de NLR foi calculado na admissão. As características dos doentes como subtipo de AVC, gravidade e diagnóstico de PSP foram obtidos. A escala A2DS2 foi utilizada como preditor clínico de PSP.

Resultados: Foram identificados 521 doentes com AIS. A idade média foi 76,17 ± 10,16 anos, 46,9% eram homens. Verificou-se uma associação entre NLR, tipo e gravidade de AVC (p <0,01), persistindo em análise estratificada após exclusão de infeção concomitante. Doentes com NLR mais elevado apresentavam défice neurológico mais grave na admissão, maior mortalidade e maior grau de dependência na alta (p >< 0,01). Foi realizada uma regressão logística para caracterizar a capacidade preditiva da NLR (≥3) e do A2DS2 (≥6) na probabilidade de desenvolver PSP (p < 0,005). O modelo explicou 17,1% (Nagelkerke R2) da variância nos diagnósticos de pneumonia, classificando corretamente 77,0% dos doentes com uma especificidade de 96,3%. Doentes com A2DS2 ≥6 (OR 8,36, p < 0,01) e doentes com NLR ≥3 (OR 2,35, p < 0,01) apresentaram um maior risco de desenvolver pneumonia.

Conclusão: NLR parece estar relacioando com a gravida[1]de dos AIS, possivelmente como marcador de ativação neuroimune. Avanços na compreensão dos efeitos imunobiológicos da isquemia no cérebro poderão levar a desenvolvimentos terapêuticos futuros. Atualmente, sendo um biomarcador relativamente pouco dispendioso, talvez exista um papel da NLR na melhoria das escalas preditoras de PSP

Downloads

Não há dados estatísticos.

Referências

Arbel Y, Finkelstein A, Halkin A, Birati Y E, Revico M, Zuzut M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225:456-60. doi:10.1016/j.atherosclerosis.2012.09.009

Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63:213-7. doi:10.1177/0003319711412763

Park BJ, Shim JY, Lee HR, Lee JH, Jung DH, Kim HB, et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta. 2011;412:925-9. doi:10.1016/j.cca.2011.01.021

Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45:1638-43. doi:10.1016/j.jacc.2005.02.054

Yu X, Li X, Li Y, Liu T, Wang R. Neutrophil-lymphocyte ratio is associated with arterial stiffness in postmenopausal women with osteoporosis. Arch Gerontol Geriatr. 2015;61:76-80. doi:10.1016/j.archger.2015.03.011

Mozos I, Malainer C, Horbanczuk J, Gug C, Stoian D, Luca CT, et al. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front Immunol. 2017;8:1058. doi:10.3389/fimmu.2017.01058

Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M. Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci. 2018;387:115-8. doi:10.1016/j.jns.2018.02.002

Zhang J, Ren Q, Song Y, He M, Zeng Y, Liu Z, et al. Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke. Medicine. 2017;96:e8624. doi:10.1097/MD.0000000000008624

Switonska M, Piekus-Słomka N, Słomka A, Sokal P, Zekanowska E, Lattanzi S. Neutrophil-to-Lymphocyte Ratio and Symptomatic Hemorrhagic Transformation in Ischemic Stroke Patients Undergoing Revascularization. Brain Sci. 2020;10:771. doi:10.3390/brainsci10110771

Lattanzi S, Cagnetti C, Rinaldi C, Angelocola S, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage. J Neurol Sci. 2018;387:98-102. doi:10.1016/j. jns.2018.01.038

Wang L, Li Y, Wang C, Guo W, Liu M. C-reactive Protein, Infection, and Outcome After Acute Ischemic Stroke: A Registry and Systematic Review. Curr Neurovasc Res. 2020;16:405-15. doi:10.2174/15672026166661910 26122011

Mengel A, Ulm L, Hotter B, Harms H, Piper SK, Grittner U, et al. Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke - the PREDICT study. BMC Neurol. 2019;19:148. doi:10.1186/s12883-019-1375-6

Lattanzi S, Di Napoli M, Ricci S, Divani AA. Matrix Metalloproteinases in Acute Intracerebral Hemorrhage. Neurotherapeutics. 2020;17:484-96. doi:10.1007/s13311-020-00839-0

Smith CJ, Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, et al. Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group. Stroke. 2015;46:2335-40. doi:10.1161/STROKEAHA.115.009617

Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110. doi:10.1186/1471-2377-11-110

Emsley HCA, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008;7:341-53. doi:10.1016/S1474- 4422(08)70061-9

Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401-10. doi:10.1038/ nrneurol.2012.98

Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Houth JG, Weber UJ, et al. Early infection and prognosis after acute stroke: the Copenhagen Stroke Study. J stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2001;10:217-21. doi:10.1053/jscd.2001.30366

Meisel A, Smith CJ. Stroke: Preventive antibiotics for stroke-associated pneumonia. Nat Rev Neurol. 2015;11:672-3. doi:10.1038/nrneurol.2015.220

Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, O’Fallon WM. Cause- -specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828-32. doi:10.1161/01.STR.0000080534.98416.A0

Wang PL, Zhao XQ, Yang ZH, Wang AX, Wang CX, Liu LP, et al. Effect of in-hospital medical complications on case fatality post-acute ischemic stroke: data from the China National Stroke Registry. Chin Med J. 2012;125:2449-54.

Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105-18. doi:10.1016/S1474-4422(09)70266-2

Vermeij FH, Scholte op Reimer WJ, de Man P, Oostenbrugge R J V, Franke C L, Jong G, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27:465-71. doi:10.1159/000210093

Smith CJ, Bray BD, Hoffman A, Meisel A, Heuschmann P U, Wolfe C D A, et al. Can a novel clinical risk score improve pneumonia prediction in acute stroke care? A UK multicenter cohort study. J Am Heart Assoc. 2015;4:e001307. doi:10.1161/JAHA.114.001307

Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y, et al. Novel risk score to predict pneumonia after acute ischemic stroke. Stroke. 2013;44:1303-09. doi:10.1161/STROKEAHA.111.000598

Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology. 2011;77:1338-45. doi:10.1212/WNL.0b013e31823152b1

Harms H, Grittner U, Dröge H, Meisel A. Predicting post-stroke pneu monia: the PANTHERIS score. Acta Neurol Scand. 2013;128:178-84. doi:10.1111/ane.12095

Koennecke H-C, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011;77:965-72. doi:10.1212/ WNL.0b013e31822dc795

Ingeman A, Andersen G, Hundborg HH, Svendsen ML, Johnsen SP. In- -hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke. 2011;42:3214-8. doi:10.1161/STROKEAHA.110.610881

Katzan IL, Dawson N V, Thomas CL, Votruba ME, Cebul RD. The cost of pneumonia after acute stroke. Neurology. 2007;68:1938-43. doi:10.1212/01.wnl.0000263187.08969.45

Kwon HM, Jeong SW, Lee SH, Yoon BW. The pneumonia score: a simple grading scale for prediction of pneumonia after acute stroke. Am J Infect Control. 2006;34:64-8. doi:10.1016/j.ajic.2005.06.011

Sellars C, Bowie L, Bagg J, Sweeney M P, Miller H, Tilston J, et al. Risk fac tors for chest infection in acute stroke: a prospective cohort study. Stroke. 2007;38:2284-91. doi:10.1161/STROKEAHA.106.478156

Chumbler NR, Williams LS, Wells CK, Lo AC, Nadeau S, Peixoto AJ, et al. Derivation and validation of a clinical system for predicting pneumonia in acute stroke. Neuroepidemiology. 2010;34:193-9. doi:10.1159/000289350

Hoffmann S, Malzahn U, Harms H, Koennecke H C, Berger K, Kalic M, et al. Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke. 2012;43:2617-23. doi:10.1161/STROKEAHA.112.653055

Zapata-Arriaza E, Moniche F, Blanca PG, Bustamante A, Martínez IE, Uclés O, et al. External Validation of the ISAN, A2DS2, and AIS-APS Scores for Predicting Stroke-Associated Pneumonia. J stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2018;27:673-6. doi:10.1016/j.jstrokecerebrovas dis.2017.09.059

Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H. The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett. 2011;2:735-40. doi:10.3892/ol.2011.304

Schwartz M, Moalem G. Beneficial immune activity after CNS injury: prospects for vaccination. J Neuroimmunol. 2001;113:185-92. doi:10.1016/ s0165-5728(00)00447-1

Hou D, Wang C, Ye X, Zhong P, Wu D. Persistent inflammation worsens short-term outcomes in massive stroke patients. BMC Neurol. 2021;21:62. doi:10.1186/s12883-021-02097-9

Macrez R, Ali C, Toutirais O, Mauff BL, Defer G, Dirnagl H, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471-80. doi:10.1016/S1474-4422(11)70066-7

Peng Y, Wang D, Zhang J, Xue X, Wang Z, Tong W, et al. Relationship between white blood cell count at admission and short term outcome in patients with acute cerebral infarction. Clin Invest Med. 2011;34:E249. doi:10.25011/cim.v34i4.15368

Elkind MS V, Cheng J, Rundek T, Boden-Albala B, Sacco RL. Leukocyte count predicts outcome after ischemic stroke: the Northern Manhat tan Stroke Study. J stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2004;13:220-7. doi:10.1016/j.jstrokecerebrovasdis.2004.07.004

Kazmierski R, Guzik P, Ambrosius W, Ciesielska A, Moskal J, Kozubski W. Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg. 2004;107:38-43. doi:10.1016/j.clineuro.2004.03.003

Nardi K, Milia P, Eusebi P, Paciaroni M, Caso V, Agnelli G. Admission leu kocytosis in acute cerebral ischemia: influence on early outcome. J stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2012;21:819-24. doi:10.1016/j. jstrokecerebrovasdis.2011.04.015

Tamhane UU, Aneja S, Montgomery D, Rogers E-K, Eagle KA, GurmHS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-7. doi:10.1016/j.amjcard.2008.05.006

Giede-Jeppe A, Bobinger T, Gerner ST, Sembill JA, Sprügel MI, Beuscher VD, et al. Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage. Cerebro vasc Dis. 2017;44:26-34. doi:10.1159/000468996

Qun S, Tang Y, Sun J, Liu Z, Wu J, Zhang J, et al. Neutrophil-To-Lympho cyte Ratio Predicts 3-Month Outcome of Acute Ischemic Stroke. Neurotox Res. 2017;31:444-52. doi:10.1007/s12640-017-9707-z

Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb blood flow Metab Off J Int Soc Cereb Blood Flow Metab. 2015;35:888-901. doi:10.1038/jcbfm.2015.45

Jian Z, Liu R, Zhu X, Smerin D, Zhong Y, Gu L, et al. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke. Front Immunol. 2019;10:2167. doi:10.3389/fimmu.2019.02167

Malone K, Amu S, Moore AC, Waeber C. Immunomodulatory Therapeutic Strategies in Stroke. Front Pharmacol. 2019;10:630. doi:10.3389/ fphar.2019.00630

Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators Inflamm. 2016;2016:8191254. doi:10.1155/2016/8191254

Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, Fernández-Jiménez G, et al. Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil- -lymphocyte ratio. PLoS One. 2017;12:e0173947. doi:10.1371/journal. pone.0173947

de Jager CPC, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One. 2012;7:e46561. doi:10.1371/journal.pone.0046561

Holub M, Beran O, Kaspríková N, Chalupa P. Neutrophil to lymphocyte count ratio as a biomarker of bacterial infections. Cent Eur J Med. 2012;7:258-61. doi:10.2478/s11536-012-0002-3

Nam K-W, Kim TJ, Lee JS, Kwon HM, Lee YS, Ko SB, et al. High Neutrophil-to-Lymphocyte Ratio Predicts Stroke-Associated Pneumonia. Stroke. 2018;49:1886-92. doi:10.1161/STROKEAHA.118.021228

Huang GQ, Lin YT, Wu YM, Cheng QQ, Cheng HR, Wang Z. Individualized Prediction Of Stroke-Associated Pneumonia For Patients With Acute Ischemic Stroke. Clin Interv Aging. 2019;14:1951-62. doi:10.2147/CIA. S225039

Lan Y, Sun W, Chen Y, Miao J, Li G, Qiu X, et al. Nomogram Including Neutrophil-to-Lymphocyte Ratio for the Prediction of Stroke-Associated Infections. Front Neurol. 2020;11:574280. doi:10.3389/fneur.2020.574280

Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87:779-89. doi:10.1189/jlb.1109766

Jin R, Liu L, Zhang S, Nanda A, Li G. Role of Inflammation and Its Mediators in Acute Ischemic Stroke. J Cardiovasc Transl Res. 2013;6:834-51. doi:10.1007/s12265-013-9508-6

Lindsberg PJ, Carpe´n O, Paetau A, Karjalainen-Lindsberg ML, Kaste M. Endothelial ICAM-1 Expression Associated With Inflammatory Cell Response in Human Ischemic Stroke. Circulation. 1996;94:939-45. doi:10.1161/01.CIR.94.5.939

Denes A, Vidyasagar R, Feng J, Narvainen J,McColl BW, Kauppinen RA, et al. Proliferating Resident Microglia after Focal Cerebral Ischaemia in Mice. J Cereb Blood Flow Metab. 2007;27:1941-53. doi:10.1038/ sj.jcbfm.9600495

Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med. 2002;8:1363-8. doi:10.1038/nm1202-1363 62. Döring Y, Drechsler M, Soehnlein O, Weber C. Neutrophils in atherosclerosis: from mice to man. Arterioscler Thromb Vasc Biol. 2015;35:288-95. doi:10.1161/ATVBAHA.114.303564

Downloads

Publicado

22-03-2022

Como Citar

1.
Pedro D, Narciso M, Alves M, Passos Fonseca T. Relação Neutrófilo-Linfócito: Acrescentando um Biomarcador a uma Escala Preditiva de Pneumonia Pós-Acidente Vascular Cerebral . RPMI [Internet]. 22 de Março de 2022 [citado 25 de Maio de 2022];29(1):26-32. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/512

Edição

Secção

Artigos Originais